Oregon State University scientists achieved a breakthrough by observing Alzheimer's disease development in real time at the molecular level. They watched how copper ions trigger harmful protein clumping in the brain, which blocks communication between brain cells. Most importantly, they discovered that specific molecules called chelators can interrupt or even reverse this damaging process. The team used specialized measurement techniques to track these interactions second by second, revealing why some treatments work better than others. This research provides new hope that Alzheimer's brain damage might be reversible with the right targeting approach, potentially leading to more effective treatments in the future.
